Cargando…

Impact of phenylalanine on cognitive, cerebral, and neurometabolic parameters in adult patients with phenylketonuria (the PICO study): a randomized, placebo-controlled, crossover, noninferiority trial

BACKGROUND: The population of adult patients with early-treated phenylketonuria (PKU) following newborn screening is growing substantially. The ideal target range of blood phenylalanine (Phe) levels in adults outside pregnancy is a matter of debate. Therefore, prospective intervention studies are ne...

Descripción completa

Detalles Bibliográficos
Autores principales:	Trepp, Roman, Muri, Raphaela, Abgottspon, Stephanie, Bosanska, Lenka, Hochuli, Michel, Slotboom, Johannes, Rummel, Christian, Kreis, Roland, Everts, Regula
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7020385/ https://www.ncbi.nlm.nih.gov/pubmed/32054509 http://dx.doi.org/10.1186/s13063-019-4022-z

Ejemplares similares

Correction to: Impact of phenylalanine on cognitive, cerebral, and neurometabolic parameters in adult patients with phenylketonuria (the PICO study): a randomized, placebo-controlled, crossover, noninferiority trial
por: Trepp, Roman, et al.
Publicado: (2020)

Cortical thickness and its relationship to cognitive performance and metabolic control in adults with phenylketonuria
por: Muri, Raphaela, et al.
Publicado: (2022)

Neural correlates of working memory and its association with metabolic parameters in early-treated adults with phenylketonuria
por: Abgottspon, Stephanie, et al.
Publicado: (2022)

Compromised white matter is related to lower cognitive performance in adults with phenylketonuria
por: Muri, Raphaela, et al.
Publicado: (2023)

Health-related quality of life in a european sample of adults with early-treated classical PKU
por: Maissen-Abgottspon, Stephanie, et al.
Publicado: (2023)

Age-Related Psychophysiological Vulnerability to Phenylalanine in Phenylketonuria
por: Leuzzi, Vincenzo, et al.
Publicado: (2014)

Therapeutic implication of L-phenylalanine aggregation mechanism and its modulation by D-phenylalanine in phenylketonuria
por: Singh, Virender, et al.
Publicado: (2014)

Mutations of the phenylalanine hydroxylase gene in Iranian patients with phenylketonuria
por: Biglari, Alireza, et al.
Publicado: (2015)

Blood phenylalanine instability strongly correlates with anxiety in phenylketonuria
por: Didycz, Bozena, et al.
Publicado: (2017)

Phenylalanine free infant formula in the dietary management of phenylketonuria
por: Yilmaz, Ozlem, et al.
Publicado: (2023)

High phenylalanine levels directly affect mood and sustained attention in adults with phenylketonuria: a randomised, double-blind, placebo-controlled, crossover trial
por: ten Hoedt, Amber E., et al.
Publicado: (2010)

Mutations of the phenylalanine hydroxylase gene in patients with phenylketonuria in Shanxi, China
por: Zhou, Yong-An, et al.
Publicado: (2012)

Mutation analysis of Phenylalanine hydroxylase gene in Iranian patients with Phenylketonuria
por: Rastegar Moghadam, Mahsa, et al.
Publicado: (2018)

Comparison of phenylalanine tolerance in singleton and twin pregnancies in patients with phenylketonuria
por: Hozyasz, Kamil Konrad, et al.
Publicado: (2020)

Phenylalanine hydroxylase mRNA rescues the phenylketonuria phenotype in mice
por: Cacicedo, Maximiliano L., et al.
Publicado: (2022)

Fear and discomfort of children and adolescents during MRI: ethical consideration on research MRIs in children
por: Everts, Regula, et al.
Publicado: (2021)

Neuroradiological findings of an adolescent with early treated phenylketonuria: is phenylalanine restriction enough?
por: Beckhauser, Mayara Thays, et al.
Publicado: (2011)

Phenylketonuria in the Latvian population: Molecular basis, phenylalanine levels, and patient compliance
por: Kreile, M., et al.
Publicado: (2020)

Comprehensive characterization of cardiac morphology and function in adult patients with phenylketonuria using CMR
por: Hassel, Jan-Hendrik, et al.
Publicado: (2014)

Preparation of a Selective L-Phenylalanine Imprinted Polymer Implicated in Patients with Phenylketonuria
por: Najafizadeh, Parvaneh, et al.
Publicado: (2014)

Formulation and PEGylation optimization of the therapeutic PEGylated phenylalanine ammonia lyase for the treatment of phenylketonuria
por: Bell, Sean M., et al.
Publicado: (2017)

Long-Term Metabolic Correction of Phenylketonuria by AAV-Delivered Phenylalanine Amino Lyase
por: Tao, Rui, et al.
Publicado: (2020)

Improving phenylalanine and micronutrients status of children with phenylketonuria: a pilot randomized study
por: Zamani, Reza, et al.
Publicado: (2021)

Long-Term Metabolic Correction of Phenylketonuria by AAV-Delivered Phenylalanine Amino Lyase
por: Tao, Rui, et al.
Publicado: (2022)

Improved attention linked to sustained phenylalanine reduction in adults with early‐treated phenylketonuria
por: Bilder, Deborah A., et al.
Publicado: (2021)

Complications of the Low Phenylalanine Diet for Patients with Phenylketonuria and the Benefits of Increased Natural Protein
por: McWhorter, Nicole, et al.
Publicado: (2022)

Phenylalanine Tolerance over Time in Phenylketonuria: A Systematic Review and Meta-Analysis
por: Pinto, Alex, et al.
Publicado: (2023)

An Approach to Neurometabolic Epilepsy in Children with an Underlying Neurometabolic Disorder
por: KARIMZADEH, Parvaneh, et al.
Publicado: (2020)

Propagation of Plasma L-Phenylalanine Concentration Fluctuations to the Neurovascular Unit in Phenylketonuria: An in silico Study
por: Taslimifar, Mehdi, et al.
Publicado: (2019)

The spectrum of phenylalanine hydroxylase variants and genotype–phenotype correlation in phenylketonuria patients in Gansu, China
por: Zhang, Chuan, et al.
Publicado: (2023)

Aspartame and Phenylketonuria: an analysis of the daily phenylalanine intake of aspartame-containing drugs marketed in France
por: Maler, Victor, et al.
Publicado: (2023)

Lipid nanoparticle delivers phenylalanine ammonia lyase mRNA to the liver leading to catabolism and clearance of phenylalanine in a phenylketonuria mouse model
por: Diaz-Trelles, Ramon, et al.
Publicado: (2022)

Effect of Age at Pediatric Stroke on Long-term Cognitive Outcome
por: Abgottspon, Stephanie, et al.
Publicado: (2022)

MON-189 Glycemic Control and the Presence of Complications in Glycogen Storage Disease Type I: Results from the Swiss Registry
por: Kaiser, Nathalie, et al.
Publicado: (2019)

Doxycycline hinders phenylalanine fibril assemblies revealing a potential novel therapeutic approach in phenylketonuria
por: De Luigi, Ada, et al.
Publicado: (2015)

The evaluation of phenylalanine levels in Estonian phenylketonuria patients during eight years by electronic laboratory records
por: Lilleväli, Hardo, et al.
Publicado: (2019)

The Impact of Phenylalanine Levels on Cognitive Outcomes in Adults With Phenylketonuria: Effects Across Tasks and Developmental Stages
por: Romani, Cristina, et al.
Publicado: (2017)

Effect of dietary regime on metabolic control in phenylketonuria: Is exact calculation of phenylalanine intake really necessary?
por: Rohde, Carmen, et al.
Publicado: (2015)

Intrinsic property of phenylalanine to trigger protein aggregation and hemolysis has a direct relevance to phenylketonuria
por: Anand, Bibin G., et al.
Publicado: (2017)

Cognitive Outcomes and Relationships with Phenylalanine in Phenylketonuria: A Comparison between Italian and English Adult Samples
por: Romani, Cristina, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_m8h9bjbv2fgv37cifg04cmqs0n